دورية أكاديمية
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
العنوان: | Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC |
---|---|
المؤلفون: | Longval, ThomasAff1, IDs41409024022029_cor1, Leprêtre, Anne-Claire, Ravinet, Aurélie, Fayard, Amandine, Forcade, Edouard, Coman, Tereza, Redjoul, Rabah, Berceanu, Ana, Buchbinder, Nimrod, Berlie, Guillaume, Mappoura, Maria, Giannotti, Federica, Chevillon, Florian, Robin, Marie, Peffault de Latour, Régis, Sicre de Fontbrune, FloreAff11, IDs41409024022029_cor16 |
المصدر: | Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 59(6):893-895 |
قاعدة البيانات: | Springer Nature Journals |
كن أول من يترك تعليقا!